Patienterne i studie V randomiseredes til samme faste abataceptdosis eller 3 mg/ kg infliximab eller placebo i 6 måneder.
Study V patients were randomized to receive this same fixed dose of abatacept or 3 mg/ kg infliximab or placebo for 6 months.